Generally Good Indian Pharma Companies

[RapAdmin]

If someone is buying from India, I would suggest targeting medications from only the largest of the Pharma companies (i.e. top 15 or so companies). There are many smaller pharma companies, that don’t adhere to international quality standards it seems.

Here is a list I found that may be helpful in this quest (Source here)

In this article, we will explore the Top 20 Pharmaceutical Companies in India and their contributions to the industry.

COMPANY NAME	FOUNDING YEAR	FOUNDER	HEADQUARTERS	VALUATION	REVENUE 2022 (CONSOLIDATED)	REVENUE (STANDALONE)	ACQUISITIONS	IPO STATUS
Sun Pharmaceutical Industries	1983	Dilip Shanghvi	Goregaon, Mumbai	$26.2 Billion	$4.95 Billion	$2.07 Billion	12	Public
Divi’s Laboratories	1990	Murali Divi	Hyderabad	$12.6 Billion	$1.13 Billion	$1.1 Billion	0	Public
Dr. Reddy’s Laboratories	1984	Dr. Kallam Anji Reddy	Hyderabad	$9.1 Billion	$2.7 Billion	$1.8 Billion	6	Public
Cipla Limited	1935	Khwaja Abdul Hamied	Mumbai	$9.8 Billion	$2.7 Billion	$1.7 Billion	6	Public
Emcure Pharmaceuticals	1983	Satish Ramanlal Mehta	Pune	$0.63 Billion	$762.8 Million	-	4	Registered
Biocon Limited	1978	Kiran Mazumdar-Shaw	Bengaluru	$4.9 BIllion	$1.05 Billion	$241 Million	1	Public
Torrent Pharma	1959	U. N. Mehta	Ahmedabad	$6.2 Billion	$1.09 Billion	$869.9 Million	5	Public
Lupin Limited	1968	Desh Bandhu Gupta	Mumbai	$3.6 Billion	$2.07 Billion	$1.4 Billion	9	Public
Zydus Lifesciences Limited (formerly Cadila Healthcare)	1952	Ramanbhai Patel	Ahmedabad	$4.4 Billion	$1.9 Billion	$1.02 Billion	4	Public
Aurobindo Pharma Limited	1986	P. V. Ramaprasad Reddy and K. Nityananda Reddy	Hyderabad	$4.04 Billion	$2.9 Billion	$1.4 Billion	7	Public
Intas Pharmaceuticals Limited	1976	Hasmukh Chudgar	Ahmedabad	$4.3 Billion	$2.2 Billion	-	2	Private
Glenmark Pharma Limited	1977	Gracias Saldanha	Mumbai	$1.3 Billion	$1.5 Billion	$1.09 Billion	4	Public
Mankind Pharma Limited	1995	R. C. Juneja and Rajeev Juneja	New Delhi		$1 Billion	-	1	Private
Piramal Enterprises Limited	1984	Ajay Piramal	Mumbai	$5.5 Billion	$1.8 Billion	$337.3 Million	7	Public
Laurus Labs Ltd.	2005	Dr. Satyanarayana Chava	Hyderabad	$3.4 Billion	$619.8 Million	$591.1 Million	1	Public
Abbott India Ltd.	1944	Dr Wallace Calvin Abbott	Mumbai	$5.3 Billion	-	$625.7 Million	1	Public
Alkem Laboratories	1973	Samprada Singh	Mumbai	$4.7 Billion	$1.3 Billion	$1.1 Billion	3	Public
Alembic Pharmaceuticals	1907	Prof. T. K. Gajjar, Prof. A. S. Kotibhasker, B. D. Amin	Vadodara	$1.7 Billion	$670.8 Million	$632 Million	2	Public
Innovexia Life Sciences Pvt. Ltd.	2011	Sandeep Khajuria	Chandigarh	-	$14.3 Million	-	-	Private
Biophar Lifesciences Pvt. Ltd.	2010	Gulshan Rawat	Chandigarh	-	-	-	-	Private

Top 20 Pharmaceutical Companies of India

1. Sun Pharmaceutical Industries
2. Divi’s Laboratories
3. Dr. Reddy’s Laboratories
4. Cipla Limited
5. Emcure Pharmaceuticals
6. Biocon Limited
7. Torrent Pharma
8. Lupin Limited
9. Zydus Lifesciences Limited (formerly Cadila Healthcare)
10. Aurobindo Pharma Limited
11. Intas Pharmaceuticals Limited
12. Glenmark Pharma Limited
13. Innovexia Life Sciences Pvt. Ltd.
14. Biophar Lifesciences Pvt.Ltd.
15. Mankind Pharma Limited
16. Piramal Enterprises Limited
17. Laurus Labs Ltd.
18. Abbott India Ltd.
19. Alkem Laboratories
20. Alembic Pharmaceuticals

[adssx]

@RapAdmin

I would suggest targeting medications from only the largest of the Pharma companies (i.e. top 15 or so companies)

In this list I would only buy from companies that also sell in Europe and the US. Higher standards.

[RapAdmin]

Yes - that is probably a good idea, but it takes a little more research to figure out those companies that do sell to Western Europe and USA. I’d guess that its these from the top of my head, but if anyone knows better, please post:

1. Sun Pharmaceutical Industries
2. Dr. Reddy’s Laboratories
3. Cipla Limited
4. Biocon Limited
5. Zydus Lifesciences Limited (formerly Cadila Healthcare)
6. Intas Pharmaceuticals Limited
7. Glenmark Pharma Limited
8. Abbott India Ltd.

[adssx]

Lupin is also massive in the US: Lupin Limited - Wikipedia

And Aurobindo has apparently a strong presence in the US and Europe: https://www.fiercepharma.com/pharma/top-10-generic-drugmakers-2021-revenue

Also, with the exception of Intas, which is private, all the above companies are traded on the New York Stock Exchange. So they have the constant scrutiny of the markets.

[ageless64]

I notice rapacan rapamycin product is made by both Biocon and Eris. Anyone have experience or lab tests with the version made by Eris?

[RapAdmin]

No - Eris is just a marketing company, its still made by the same company Swiss Garnier. See this thread and post: Eris LifeSciences Brand of Sirolimus from India - #6 by KoolieDude17

[adssx]

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

In 2023, the USFDA conducted 225 inspections, which led to 18 cases of Official Action Indicated (OAI) and 117 cases of Voluntary Action Indicated (VAI). By 2024, despite a tightening of regulatory standards, the number of inspections dropped to 206, while OAI cases fell to 14 and VAI cases reduced to 115. This highlights that the sector is increasingly aligning with global benchmarks to ensure high-quality manufacturing practices.

https://www.business-standard.com/health/indian-pharma-improves-compliance-with-usfda-fewer-oai-cases-in-2024-124122900413_1.html

[RapAdmin]

Yes… but. The FDA currently has to give advanced notice of inspections to the Indian Pharma… and there have been many situations where Indian Pharma has been caught (insiders reveal) changing / modifying things to make them look better during the inspection… so I’m not super confident that things are that much better.